Tuesday, 04 Nov 2025

MedPulse360

Oral Blarcamesine Reduces Cognitive Decline in Phase 2b/3 Trial for Early Alzheimer Disease
14 September, 2025

Teva’s Emrusolmin Granted Fast Track Designation for Multiple System Atrophy
14 September, 2025

Improving Brain Health Through Lifestyle Changes in Older Adults at Risk for Dementia: Rebecca M. Edelmayer, PhD
14 September, 2025

NeuroVoices: Marcus Yountz, on the Promise and Phase 2 Data of Orexin Agent Alixorexton
14 September, 2025

Monitoring and Managing ARIA in Antiamyloid Treatments
14 September, 2025

RAP-219 Meets Primary End Point in Phase 2a Trial for Focal-Onset Seizures
14 September, 2025

Phase 3 Argus Interim Data Support Safety of EPX-100 as Adjunctive Therapy for Dravet Syndrome
14 September, 2025

FDA Action Update, August 2025: Approvals and Complete Response Letter
14 September, 2025

Mesenchymal Stem Cell Approach Meets End Points in Placebo-Controlled Trial of Parkinson Disease
14 September, 2025

Optimizing Multidisciplinary Care and Emerging Therapies to Support Independence in Advanced DMD
14 September, 2025
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago